News from the world
14
Jul
China NMPA conducts management review of QMS for regulation of vaccine and drug GMP compliance
The National Medical Products Administration (NMPA) conducted its 2025 annual management review of the Quality Management System (QMS) for regulation of vaccine and drug Good Manufacturing Practice (GMP) compliance on June 30. NMPA Commissioner Huang Guo presided over the meeting and fully affirmed the suitability, adequacy and effectiveness of the NMPA's QMS in both areas...[NMPA]
17
Jul
Inside Pharma’s Push for More Resilient Supply Chains
Industry leaders from Samsung Biologics and Fujifilm Biotechnologies discuss how regional manufacturing,...
17
Jul
US FDA CDER plans new guidance on AI, electronic safety report submissions, and more
The US Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) has...
16
Jul
EU DG SANTE and EMA sign Working Arrangement with New Zealand Ministry of Health
DG SANTE and the European Medicines Agency (EMA) have signed a Working Arrangement with New Zealand Ministry...
15
Jul
Riforma farmaceutica. Via libera della Commissione Sanità del Senato
Le poche modifiche approvate non cambiano l'impianto della riforma. L’articolo 3 a...
latest news
17 Jul
Inside Pharma’s Push for More Resilient Supply Chains
17 Jul
US FDA CDER plans new guidance on AI, electronic safety report submissions, and more
16 Jul
EU DG SANTE and EMA sign Working Arrangement with New Zealand Ministry of Health
15 Jul
Riforma farmaceutica. Via libera della Commissione Sanità del Senato
14 Jul
China NMPA conducts management review of QMS for regulation of vaccine and drug GMP compliance
14 Jul
AIFA: “Cerca un farmaco”: disponibili nuove informazioni sullo stato di commercializzazione dei medicinali
13 Jul
ECHA: riforma dell’Agenzia europea delle sostanze chimiche
13 Jul
US FDA Proposes Rule to Modernize Drug Manufacturing Registration